At a glance
ClinicalIndex Comparison RecordN/ACompleted· 152 enrolled
Drug / intervention
Routine substrate ablation without pulmonary vein Isolation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Substrate Ablation Guided by Automatic High Density Mapping for the Treatment of Atrial Fibrillation
In Brief
An observational study evaluating Routine substrate ablation without pulmonary vein Isolation and Routine conventional ablation with pulmonary vein Isolation for Atrial Fibrillation. Completed, enrolled 152 participants across 3 sites.
Detailed Summary
To evaluate a new AF Substrate mapping method based on automatic high density CFAE detection with a multipolar catheter (Pentaray) and the " SCI 30-40 " setting of CARTO CFAE algorithm.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedMar 2014
Primary CompletionDec 2014
Study CompletionAug 2016
TodayJul 2026
First PostedMar 21, 2014
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2014
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.3 years ago
Interventions
Routine substrate ablation without pulmonary vein Isolationprocedure
Routine conventional ablation with pulmonary vein Isolationprocedure